Clinical Trials Logo

Clinical Trial Summary

In the Congenital Myopathy Research Program at Boston Children's Hospital and Harvard Medical School, the researchers are studying the congenital myopathies (neuromuscular diseases present from birth), including central core disease, centronuclear/myotubular myopathy, congenital fiber type disproportion, multiminicore disease, nemaline myopathy, rigid spine muscular dystrophy, SELENON (SEPN1), RYR1 myopathy, ADSS1 (ADSSL) Myopathy and undefined congenital myopathies. The primary goal of the research is to better understand the genes and proteins (gene products) involved in muscle functioning and disease. The researchers hope that our studies will allow for improved diagnosis and treatment of individuals with congenital myopathies in the future. For more information, visit the Laboratory Website at www.childrenshospital.org/research/beggs


Clinical Trial Description

The Congenital Myopathy Research Program consists of a group of scientists and healthcare providers all working to better understand the congenital myopathies. We are taking two approaches to reach our research goals. The first involves identifying and describing new genes and proteins involved in the skeletal muscles that allow our bodies to move. Simultaneously, studies are underway to identify genetic changes (mutations) that cause human neuromuscular disease. Thus, our second approach is to identify mutations, learn how they are inherited in families, and understand how they lead to weakness in individuals with neuromuscular disease. These approaches allow correlation of our basic muscle biology findings with our studies on muscle tissue of affected individuals. Our research would not be possible without the generous participation of individuals and families with congenital myopathies. Participation in our studies is free of charge. Travel to Boston is not required, and we welcome the participation of individuals from around the world. We appreciate the participation of all individuals with a congenital myopathy, as well as their first-degree relatives. Participants with a congenital myopathy are asked to donate medical records, a blood or saliva sample, and a muscle tissue sample (if available). Participating relatives are asked to donate a blood sample. The blood/saliva sample is used to acquire DNA (genetic material) which can be used to identify genetic changes and to study how a disease is inherited in a family. The medical records are employed to understand a participant's symptoms. The muscle tissue is used to better understand the disease at the muscular level by studying the gene expression and protein levels in individuals with congenital myopathies. For more information, visit the Laboratory Website at www.childrenshospital.org/research/beggs. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00272883
Study type Observational
Source Boston Children's Hospital
Contact Casie Genetti, M.S. C.G.C.
Phone (617) 919-2169
Email BeggsLabGC@childrens.harvard.edu
Status Recruiting
Phase
Start date August 2003
Completion date January 2050

See also
  Status Clinical Trial Phase
Withdrawn NCT04977648 - Natural History Study of Patients With Centronuclear Myopathies
Enrolling by invitation NCT05099107 - Changes of Motor Function Tests in Congenital Myopathy Subjects Treated With Oral Salbutamol as Compared to no Treatment N/A
Completed NCT03351270 - Prospective Natural History Study of Patients With Myotubular Myopathy and Other CentroNuclear Myopathies N/A
Recruiting NCT04064307 - Myotubular and Centronuclear Myopathy Patient Registry
Recruiting NCT05982119 - Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next Study N/A
Terminated NCT04033159 - Early Phase Human Drug Trial to Investigate Dynamin 101 (DYN101) in Patients ≥ 16 Years With Centronuclear Myopathies Phase 1/Phase 2
Withdrawn NCT04743557 - Early Phase Human Drug Trial to Investigate DYN101 in Participants 2 to 17 Years With Centronuclear Myopathies Phase 1/Phase 2
Not yet recruiting NCT06157268 - The Natural History and Muscle Fatigability of Patients With Congenital Myopathies.